Pediatric Hematology

Understanding JAGN1 Severe Congenital Neutropenia

At a Glance

JAGN1 severe congenital neutropenia is a rare inherited disorder that leaves children with too few infection-fighting neutrophils. Fever or serious illness requires immediate evaluation; care often includes neutrophil-boosting injections, dental care, monitoring, and stem cell transplant planning.

Learning that your child has JAGN1 severe congenital neutropenia (SCN) can be overwhelming. You may have spent months or even years dealing with mysterious, frequent infections that seemed to come out of nowhere ^[1]. It is important to know that these infections are the result of a rare genetic condition, not a reflection of your parenting, hygiene, or care ^[2].

Understanding the JAGN1 Diagnosis

JAGN1-SCN is an extremely rare type of severe congenital neutropenia, a condition where the body does not produce enough neutrophils—the “first responder” white blood cells that fight bacterial and fungal infections ^[3]^[4].

In JAGN1-SCN, the problem lies in the JAGN1 protein, which helps white blood cells mature and function correctly ^[5]. Without a working JAGN1 protein, neutrophils may get “stuck” in the bone marrow or fail to work properly when they do reach the blood ^[6]^[7].

This condition is autosomal recessive, meaning a child must inherit two copies of the changed gene (one from each parent) to have the disorder ^[8]. Usually, parents are healthy “carriers” and have no idea they carry the gene until their child is diagnosed ^[9].

Why Fever Is an Emergency

For most children, a fever is a sign the body is fighting an infection. For a child with SCN, a fever is a sign that an infection has started, but the body lacks the “soldiers” (neutrophils) to fight back ^[3]. This can allow a minor infection to become a life-threatening emergency, like sepsis (a dangerous full-body reaction to infection), very quickly ^[4]^[10].

Always follow the specific written emergency protocol provided by your hematology team. General guidelines often define a fever as:

A single temperature of 101°F (38.3°C) or higher ^[11].
A temperature of 100.4°F (38.0°C) that lasts for an hour or more ^[10].

Do not delay medical evaluation while trying to locate a fever letter or contacting the specialty team. Also, do not give fever-reducing medications like acetaminophen before speaking with your doctor, as this can mask the fever. Remember that a child with profound neutropenia may not mount a fever at all; lethargy, breathing difficulty, rigors (shaking chills), hypotension, new severe pain, or rapidly worsening illness should trigger immediate medical contact.

In an emergency setting, your child will likely need blood cultures and empiric antibiotics—powerful, broad-spectrum antibiotics given immediately, often before the specific cause of the fever is known ^[12]^[13].

Managing Daily Life and Treatment

The primary goal of treatment is to raise the Absolute Neutrophil Count (ANC) and prevent infections ^[14].

G-CSF Therapy: Most children are treated with daily injections of G-CSF (granulocyte colony-stimulating factor), a medicine that tells the bone marrow to make more neutrophils ^[14]. Some children with JAGN1 mutations may be “low responders,” meaning they need higher doses to see an effect ^[9]^[15].
Dental and Oral Care: JAGN1-SCN is frequently associated with severe gingivitis (gum inflammation) and periodontitis (gum disease) ^[16]. Regular dental check-ups with a specialist who understands neutropenia are vital to preventing early tooth loss ^[4]^[17].
Monitoring: Your child will need regular blood tests and periodic bone marrow biopsies to monitor how well the treatment is working and to watch for any changes in the bone marrow cells ^[14]^[18].
Bone Marrow Transplant: If G-CSF does not work or if infections remain severe, your doctor may discuss hematopoietic stem cell transplantation (HSCT), which can potentially correct the neutropenia ^[19]^[15].

The Emotional Weight of Caregiving

The constant “high alert” required to protect a child with SCN can lead to significant emotional exhaustion ^[2]. It is normal to feel anxious about every cough or scrape. While you must remain vigilant, remember that your child’s medical team is there to share this burden. Connecting with other families through SCN support groups can provide practical advice and emotional validation from those who truly understand the “neutropenic life” ^[2].

Common questions in this guide

What is JAGN1 severe congenital neutropenia?

JAGN1 severe congenital neutropenia is a rare inherited condition caused by changes in both copies of the JAGN1 gene. The gene helps neutrophils, which are infection-fighting white blood cells, develop and function. Affected children may have very low neutrophil counts and serious infections.

When is a fever an emergency for a child with JAGN1-SCN?

Always follow the fever plan written by your child’s hematology team. Many protocols treat a single temperature of 101°F (38.3°C) or higher, or a temperature of 100.4°F (38.0°C) lasting an hour, as an emergency. Seek immediate medical help for concerning symptoms even if your child does not have a fever, because profound neutropenia can blunt the fever response.

How is JAGN1 severe congenital neutropenia treated?

Daily G-CSF injections are commonly used to stimulate the bone marrow to make more neutrophils, although some children need higher doses or respond less strongly. Fever may require immediate blood cultures and broad-spectrum antibiotics. If G-CSF is ineffective or infections remain severe, the medical team may discuss a hematopoietic stem cell transplant.

Can JAGN1-SCN affect a child’s gums and teeth?

Yes. JAGN1-SCN is often associated with severe gingivitis and periodontitis, which can damage the gums and lead to early tooth loss. Regular examinations with a dentist familiar with neutropenia can help prevent and manage these problems.

Why are blood tests and bone marrow biopsies needed in JAGN1-SCN?

Blood tests track the absolute neutrophil count and show how well treatment is working. Periodic bone marrow biopsies help the medical team evaluate blood-cell development and watch for changes in the marrow. The timing depends on your child’s blood counts, treatment response, and specialist plan.

When might a stem cell transplant be considered for JAGN1-SCN?

A hematopoietic stem cell transplant may be discussed when G-CSF does not raise neutrophil counts enough or serious infections continue despite treatment. It can potentially correct the neutropenia, but the decision depends on your child’s health, donor options, treatment response, and specialist assessment.

Should family members have genetic testing after a JAGN1 diagnosis?

Because JAGN1-SCN is inherited in an autosomal recessive pattern, a child usually receives one changed gene copy from each parent, who may be healthy carriers. A genetic counselor can explain whether parents, siblings, or other relatives may benefit from targeted testing and what the results could mean for family planning.

Get notified when new evidence is published on Severe congenital neutropenia due to JAGN1 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (19)

1
Clinical outcome and infectious complications in genetic and suspected genetic neutropenia: A report from the Canadian Inherited Marrow Failure Registry.
Choi YB, Alshammari NRR, Mathew R, et al.
British journal of haematology 2026; doi:10.1111/bjh.70823.
PMID: 42817075
2
Family Knowledge, Attitudes, and Practices Toward Severe Congenital Neutropenia.
Karadaş N, Yilmaz Y, Önen Göktepe Ş, et al.
Journal of pediatric hematology/oncology 2023; (45(4)):e441-e445 doi:10.1097/MPH.0000000000002634.
PMID: 36897312
3
Severe Congenital Neutropenia in a Newborn Caused by a Novel Mutation in the ELANE Gene-First Report From North Macedonia and a Literature Review: A Case Report.
Zdraveska N, Trajkovska T, Jovanovska A, et al.
Case reports in pediatrics 2025; (2025()):6873929 doi:10.1155/crpe/6873929.
PMID: 41477439
4
Manifestation of severe congenital neutropenia in the oral cavity. Case report.
Krasuska-Sławińska E, Klaudel-Dreszler M, Minota M, et al.
Central-European journal of immunology 2013; (48(1)):70-74 doi:10.5114/ceji.2023.125312.
PMID: 37206584
5
Jagunal homolog 1 safeguards neutrophil immune function by preserving protein sialylation during differentiation.
Nussbaumer K, Hübner M, da Costa R, et al.
Blood advances 2026; (10(21)):7311-7324 doi:10.1182/bloodadvances.2026019794.
PMID: 42685351
6
A JAGN1-associated severe congenital neutropenia zebrafish model revealed an altered G-CSFR signaling and UPR activation.
Doll L, Welte K, Skokowa J, Bajoghli B
Blood advances 2024; (8(15)):4050-4065 doi:10.1182/bloodadvances.2023011656.
PMID: 38739706
7
Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review.
Thomas S, Guenther G, Rowe JH, et al.
Frontiers in pediatrics 2023; (11()):1223191 doi:10.3389/fped.2023.1223191.
PMID: 37528877
8
JAGN1 Deficient Severe Congenital Neutropenia: Two Cases from the Same Family.
Baris S, Karakoc-Aydiner E, Ozen A, et al.
Journal of clinical immunology 2015; (35(4)):339-43 doi:10.1007/s10875-015-0156-2.
PMID: 25851723
9
Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.
Farmand S, Aydin SE, Wustrau K, et al.
Frontiers in immunology 2024; (15()):1373495 doi:10.3389/fimmu.2024.1373495.
PMID: 39286252
10
Neutropenia: Evaluation and Management in the Primary Care Setting.
Kim MJ, Forlini C, Kremsreiter K
American family physician 2025; (112(6)):618-628.
PMID: 41533406
11
Management of Neutropenic Fever in Persons with Cancer.
Doyle-Lindrud S
The Nursing clinics of North America 2025; (60(3)):479-489 doi:10.1016/j.cnur.2024.09.004.
PMID: 40716808
12
Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
Lehrnbecher T, Robinson PD, Ammann RA, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023; (41(9)):1774-1785 doi:10.1200/JCO.22.02224.
PMID: 36689694
13
Febrile Neutropenia in Children with Cancer: Approach to Diagnosis and Treatment.
Kebudi R, Kizilocak H
Current pediatric reviews 2018; (14(3)):204-209 doi:10.2174/1573396314666180508121625.
PMID: 29737253
14
Severe congenital neutropenias.
Skokowa J, Dale DC, Touw IP, et al.
Nature reviews. Disease primers 2017; (3()):17032 doi:10.1038/nrdp.2017.32.
PMID: 28593997
15
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.
Fekadu-Siebald J, Salzmann-Manrique E, Heusel JR, et al.
Blood advances 2025; (9(7)):1702-1711 doi:10.1182/bloodadvances.2024014344.
PMID: 39775668
16
Chronic neutropenia: how best to assess severity and approach management?
Donadieu J, Frenz S, Merz L, et al.
Expert review of hematology 2021; (14(10)):945-960 doi:10.1080/17474086.2021.1976634.
PMID: 34486458
17
Evaluation of periodontal status and cytokine/chemokine profile of GCF in patients with severe congenital neutropenia.
Acar B, Cagdas D, Tan Ç, et al.
Odontology 2021; (109(2)):474-482 doi:10.1007/s10266-020-00565-1.
PMID: 33159599
18
Ultra-Sensitive CSF3R Deep Sequencing in Patients With Severe Congenital Neutropenia.
Klimiankou M, Uenalan M, Kandabarau S, et al.
Frontiers in immunology 2019; (10()):116 doi:10.3389/fimmu.2019.00116.
PMID: 30891028
19
HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry.
Rotulo GA, Beaupain B, Rialland F, et al.
Bone marrow transplantation 2020; (55(8)):1614-1622 doi:10.1038/s41409-020-0800-1.
PMID: 31992846

This page is for informational purposes only and does not constitute medical advice. For a child with JAGN1 severe congenital neutropenia, follow the written fever protocol from the hematology team and seek urgent care for fever or signs of serious illness.